A Clinical trial of compound drugs for patients with type2 diabetes - Comparative analysis of the characteristics of postprandial hyperglycemia improving drugs for postprandial metabolic disorder.
Phase of Trial: Phase II
Latest Information Update: 16 May 2016
At a glance
- Drugs Mitiglinide (Primary) ; Mitiglinide/voglibose (Primary) ; Voglibose (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 04 Feb 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 05 Sep 2011 New trial record